Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma

Published:2019-10 Issue:1 Volume:383 Page:111496
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Liu Chang,Wen Chaochao,Wang Xi,Wei Yan,Xu Chunyang,Mu Xiuli,Zhang Lina,Wang Xuan,Tian Jiubo,Ma Peiyuan,Meng Fanxiu,Zhang Qi,Zhao Na,Yu Baofeng,Gong Tao,Guo Rui,Wang Hailong,Xie Jun,Sun Gongqin,Li Gaopeng,Zhang Hongwei,Qin Qin,Xu Jun,Dong Xiushan,Wang Lumei

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanxi

International Science and Technology Cooperation Project of Shanxi Provincial Key R&D Program

Shanxi Youth Science and Technology Research Fund

Publisher

Elsevier BV

Subject

Cell Biology

Reference63 articles.

1. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma;Rai;Mol. Cell. Biochem.,2017

2. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection;Liu;Neoplasma,2017